<DOC>
	<DOC>NCT01224015</DOC>
	<brief_summary>This study will evaluate the safety and efficacy of botulinum toxin type A compared to placebo for the treatment of Crow's Feet Lines and Frown Lines (Facial Rhytides) for patients who successfully completed Study 191622-099.</brief_summary>
	<brief_title>Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines</brief_title>
	<detailed_description />
	<mesh_term>Botulinum Toxins, Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Successfully completed Study 191622099 Known immunization or hypersensitivity to botulinum toxin of any serotype Anticipated need for treatment with botulinum toxin of any serotype during the study (except for study treatment) Diagnosis of myasthenia gravis, EatonLambert syndrome, or amyotrophic lateral sclerosis Anticipated need for surgery or hospitalization during the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>